Fulgent Diagnostics

Fulgent Diagnostics

Fulgent Diagnostics

A pharmaceutical and next generation molecular diagnostics company focusing on developing and commercializing cancer therapeutics and companion diagnostics.
Founded
2011
Raised
$32.6M
Follow us
Alexa global traffic share
Twitter followers
24 May 2016
$27,160,000
Venture capital

SEC FORM D

sec
14 Apr 2016
$5,400,000
Venture capital

SEC FORM D

sec